LEXARIA BIOSCIENCE CORP's ticker is LEXX and the CUSIP is 52886N406. A total of 29 filers reported holding LEXARIA BIOSCIENCE CORP in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,174 | +135.5% | 3,300 | +207.5% | 0.00% | – |
| Q1 2024 | $3,895 | +193.3% | 1,073 | +1.0% | 0.00% | – |
| Q4 2023 | $1,328 | +22.3% | 1,062 | -2.2% | 0.00% | – |
| Q3 2023 | $1,086 | +38.9% | 1,086 | +1.4% | 0.00% | – |
| Q2 2023 | $782 | -73.1% | 1,071 | +0.2% | 0.00% | – |
| Q1 2023 | $2,908 | +14.2% | 1,069 | +3.3% | 0.00% | – |
| Q4 2022 | $2,546 | +27.3% | 1,035 | +0.1% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 1,034 | +0.2% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 1,032 | +0.2% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 1,030 | +0.5% | 0.00% | – |
| Q4 2021 | $4,000 | – | 1,025 | +4000.0% | 0.00% | – |
| Q3 2021 | $0 | – | 25 | -13.8% | 0.00% | – |
| Q2 2021 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenomic Capital Management LP | 764,332 | $764,256 | 0.03% |
| ARMISTICE CAPITAL, LLC | 889,272 | $889,183 | 0.01% |
| WELLS FARGO & COMPANY/MN | 1,086 | $1,086 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 650 | $649 | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 13 | $13 | 0.00% |
| Aspire Private Capital, LLC | 400 | $399 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 47,416 | $46,985 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,545 | $10,544 | 0.00% |
| Farther Finance Advisors, LLC | 166 | $166 | 0.00% |